Image For Activity Cover
Ten Simple Tips: Cardiac Amyloidosis: No Longer an Academic Exercise, Now a Treatable Pandemic (ASNC Joint Session)

HFSA 23rd Annual Scientific Meeting

SESSION 34 - Ten Simple Tips: Cardiac Amyloidosis - No Longer an Academic Exercise, Now a Treatable Pandemic

Sep 16, 2019 8:00am - Sep 16, 2019 9:30am

Session Description
Historically, Amyloidosis was thought to be rare, untreatable and solely a disease for academic interest. In the current era, it is increasingly recognized as a more common cause of heart failure, accounting for over 10% of patients with HFpEF.  Further, effective evidence-based therapies are currently available to hinder disease progression and improve outcomes. Early diagnosis of cardiac amyloidosis is key and has a significant impact on patient survival.
Learning Objectives

As a result of this educational session, the learner will be able to:

  1. Provide an overview of amyloidosis and its various manifestations.
  2. Identify clinical pearls that arise disease suspicion and a diagnostic algorithm for timely diagnosis.
  3. Describe the role of multimodality imaging in making the diagnosis.
  4. Provide contemporary update on the management of transthyretin and light chain amyloidosis.
James Udelson , MD, Tufts New England Medical Center
Daniel Judge , MD, Medical University of South Carolina
Mazen Hanna, MD, Director, Cleveland Clinic
Omar F. Abou Ezzeddine, MDCM, MS, Mayo Clinic
Sami Khella, MD, Penn Medicine
Matthew S. Maurer, MD, Columbia University
Vaishali Sanchorawala, MD, Boston Medical Center
Justin Grodin, MD, MPH, UT Southwestern Medical Center
Availability: On-Demand
Cost: Member: $29.00
Non-Member: $45.00
Credit Offered: 1.5 CME Credits
1.5 MOC Points
Powered by Oasis.